Your Messages Inbox
Most Viewed Abstracts
1. Report Shows Shift in Starting Salaries for Physicians 2. Use of Antiemetic Agents in Acute Gastroenteritis 3. 2008 Exclusive Survey—Earnings: Good news for primary care income 4. A randomised phase III study on capecitabine, oxaliplatin and bevacizumab with or without cetuximab in first-line advanced colorectal cancer, the CAIRO2 study of the Dutch Colorectal Cancer Group (DCCG). An interim analysis of toxicity 5. Medicare pay-for-reporting effort draws fire from frustrated doctors
Your Article Summary
See Latest ArticlesResponse to adefovir or entecavir in renal allograft recipients with hepatitic flare due to lamivudine-resistant hepatitis B
Clinical Transplantation, 09/18/09
Tse KC et al. – The authors conclude that both adefovir and entecavir are effective in the treatment of lamivudine–resistant HBV in renal allograft recpients, and the reduction of HBV DNA to <105 copies/mL could be slow.
Related Articles
The Alphabet Soup of Kidney Transplantation: SCD, DCD, ECD—Fundamentals for the Practicing Nephrologist
Clinical Journal of the American Society of Nephrology, 11/16/09
Relevance Score: 70%
The Evolution of Kidney Function After Lung Transplantation: A Retrospective Cohort Study
Transplantation Proceedings, 11/11/09
Relevance Score: 70%
ABO-Incompatible Kidney Transplantation
Transplantation, 10/29/09
Relevance Score: 70%
Ethical Issues and Living Unrelated Donor Kidney Transplantation
Iranian Journal of Kidney Diseases, 10/13/09
Relevance Score: 69%
The Science of Stewardship: Due Diligence for Kidney Donors and Kidney Function in Living Kidney Donation—Evaluation, Determinants, and Implications for Outcomes
Clinical Journal of the American Society of Nephrology, 10/08/09
Relevance Score: 69%
Today in Hepatology...keeping you current
Receive free subspecialty "5-minute updates" via email
Current issues in the management of paediatric viral hepatitis
Liver International, 12/09/09
Long-term Probability of and Mortality From De Novo Malignancy After Liver Transplantation
Gastroenterology, 12/09/09
Factors That Predict Response of Patients With Hepatitis B e Antigen-Positive Chronic Hepatitis B to Peginterferon-Alfa
Gastroenterology, 12/09/09
Today in Pharmacology/kinetics...keeping you current
Receive free subspecialty "5-minute updates" via email
Update on the role of modified release mesalamine in the management of ulcerative colitis and Crohn's disease
Clinical and Experimental Gastroenterology, 12/09/09
Delayed-Release Oral Mesalamine 4.8 g/day (800-mg Tablet) Is Effective for Patients With Moderately Active Ulcerative Colitis
Gastroenterology, 12/09/09
Effect of HCV RNA Suppression During Peginterferon Alfa-2a Maintenance Therapy on Clinical Outcomes in the HALT-C Trial
Gastroenterology, 12/09/09
Sponsor
Article Search
Sponsor